Syria: A drug approved for "Corona" will be marketed today
The Syrian pharmaceutical company "Tamico" today launches a drug for treating "Corona", bearing the name "azithromycin", on the market, and it is a drug approved in the protocol for treatment and prevention of Corona virus.
The Syrian newspaper Al-Watan quoted the Syrian Ministry of Industry as saying that the new product is used to treat bronchitis and sinusitis, community-acquired pneumonia, and uncomplicated infections of the skin and skin.
It is also used in the treatment of pharyngitis, tonsillitis, genital ulcers in men, otitis media and sinusitis, and acquired pneumonia in children. The ministry stated that the new product will be marketed to meet the local market's demand for it.